OU Medicine Inc., OK Series 2018B&C Bond Rating Outlook Revised To Stable From Negative On Improved Financial Profile - S&P Global Ratings’ Credit Research

OU Medicine Inc., OK Series 2018B&C Bond Rating Outlook Revised To Stable From Negative On Improved Financial Profile

OU Medicine Inc., OK Series 2018B&C Bond Rating Outlook Revised To Stable From Negative On Improved Financial Profile - S&P Global Ratings’ Credit Research
OU Medicine Inc., OK Series 2018B&C Bond Rating Outlook Revised To Stable From Negative On Improved Financial Profile
Published Jun 01, 2020
3 pages (1397 words) — Published Jun 01, 2020
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

CHICAGO (S&P Global Ratings) June 1, 2020--S&P Global Ratings revised the outlook to stable from negative and affirmed its 'BB+' long-term rating on the Oklahoma Development Finance Authority's approximately $826 million series 2018B tax-exempt fixed-rate bonds and approximately $201 million series 2018C taxable fixed-rate bonds, and its 'BB+' underlying rating (SPUR) on the authority's $85 million insured series 2018B tax-exempt fixed-rate bonds and $50 million insured series 2018C taxable fixed-rate bonds. All bonds were issued for OU Medicine Inc. (OUMI). "The outlook revision reflects our view of OUMI's plans and initial progress in reactivating volumes and its receipt of funding from the CARES (Coronavirus Aid, Relief, and Economic Security) Act, which we think will lessen the magnitude of the erosion

  
Report Type:

Ratings Action

Issuer
Sector
Global Issuers, Public Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "OU Medicine Inc., OK Series 2018B&C Bond Rating Outlook Revised To Stable From Negative On Improved Financial Profile" Jun 01, 2020. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/OU-Medicine-Inc-OK-Series-2018B-C-Bond-Rating-Outlook-Revised-To-Stable-From-Negative-On-Improved-Financial-Profile-2452863>
  
APA:
S&P Global Ratings’ Credit Research. (). OU Medicine Inc., OK Series 2018B&C Bond Rating Outlook Revised To Stable From Negative On Improved Financial Profile Jun 01, 2020. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/OU-Medicine-Inc-OK-Series-2018B-C-Bond-Rating-Outlook-Revised-To-Stable-From-Negative-On-Improved-Financial-Profile-2452863>
  
US$ 150.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.